We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about Imfinzi (durvalumab), an immunotherapy drug used to treat various cancers like lung, biliary tract, liver, and endometrial cancers. Understand how it works, its administration, potential side effects, and when to consult a doctor.

When facing a cancer diagnosis, understanding your treatment options is paramount. Imfinzi, with the active ingredient durvalumab, is a significant advancement in cancer therapy, harnessing the power of your own immune system to fight the disease. This blog post aims to provide a clear, practical overview of Imfinzi, its uses, how it works, potential side effects, and what you can expect during treatment, tailored for our readers in India.
Imfinzi is a type of medication known as immunotherapy. Unlike traditional chemotherapy that directly attacks cancer cells, immunotherapy works by helping your immune system recognize and destroy cancer more effectively. Durvalumab, the active component in Imfinzi, is a biologic medication, meaning it’s derived from living organisms. It functions as a programmed cell death ligand 1 (PD-L1) inhibitor. PD-L1 is a protein that can prevent your immune system from attacking cancer cells. By blocking PD-L1, Imfinzi essentially releases the brakes on your immune system, allowing it to fight the cancer.
Currently, Imfinzi is not available in a biosimilar form, meaning durvalumab is only available under the brand name Imfinzi.
Imfinzi has shown effectiveness in treating several types of cancer. The primary uses include:
As an immunotherapy, Imfinzi works by targeting the PD-1/PD-L1 pathway. Cancer cells often express PD-L1 on their surface. This PD-L1 protein binds to PD-1 receptors on immune cells (T-cells), sending a signal that tells the T-cells to stand down and not attack the cancer cell. It's a way for cancer to hide from the immune system.
Durvalumab in Imfinzi acts as an antibody that blocks this PD-L1 protein. By preventing PD-L1 from binding to PD-1, Imfinzi stops the immune-suppressing signal. This 'unleashes' the T-cells, enabling them to recognize and attack the cancer cells more effectively. Think of it like removing a shield that the cancer was using to hide from your body's defence system.
Imfinzi is given as an intravenous (IV) infusion. This means a healthcare professional will administer the medication through a vein, usually in your arm. The infusion process typically takes about 60 minutes.
The dosage and frequency of Imfinzi infusions depend on several factors, including your weight and the type of cancer being treated. Your doctor will determine the most appropriate schedule for you.
Generally, for adults weighing 30 kg (about 66 lbs) or more:
For adults weighing less than 30 kg:
It is vital to adhere strictly to the schedule prescribed by your healthcare provider. Missing appointments can affect the effectiveness of the treatment.
Like all medications, Imfinzi can cause side effects, ranging from mild to serious. It's important to discuss any concerns with your doctor. Some common side effects may include:
While not common, serious side effects can occur. These often relate to the immune system overreacting and attacking healthy tissues. This is known as an immune-related adverse event (irAE). Symptoms can affect various organs and may include:
A Real-Life Scenario: Imagine Mrs. Sharma, who started Imfinzi for her lung cancer. A few weeks into treatment, she noticed a persistent, dry cough and felt unusually short of breath, especially when walking to her garden. She remembered her doctor mentioning lung-related side effects and immediately called the clinic. Her doctor advised her to come in for an evaluation, which led to early detection and management of pneumonitis, preventing it from becoming severe.
Call your doctor immediately if you experience any signs of serious side effects. If you believe you are having a life-threatening reaction or a medical emergency, call 911 or your local emergency number right away.
Your healthcare team is your best resource for managing side effects. They can:
Open communication with your doctor and nurses is key. Don't hesitate to report any new or worsening symptoms, no matter how minor they seem.
As mentioned, durvalumab, the active drug in Imfinzi, is currently only available as the brand-name drug Imfinzi. Unlike traditional medications that often have generic versions, biologic drugs like durvalumab have biosimilars. A biosimilar is a highly similar version of a biologic drug, but it's not identical. At present, there are no approved biosimilars for Imfinzi. This means patients will receive the Imfinzi brand-name product.
Before beginning treatment with Imfinzi, have a thorough discussion with your oncologist. Key points to cover include:
Imfinzi is a treatment that helps control or slow the growth of cancer and can lead to remission in some patients. It works with your immune system to fight the disease. While it is a powerful tool, the outcome depends on many factors, including the type and stage of cancer, and individual patient response.
The duration of treatment varies. It depends on the type of cancer, how your body responds to the treatment, and the overall treatment plan decided by your doctor. Your doctor will discuss the expected duration with you.
Always inform your doctor about all medications you are taking. Some drugs may interact with Imfinzi or affect your immune system. Your doctor will advise on which medications are safe to continue.
If you or a loved one is considering Imfinzi as a treatment option, or if you are currently undergoing treatment, remember that your medical team is your primary resource. Do not hesitate to reach out to your oncologist or nurse navigator with any questions or concerns. They are there to guide you through every step of the treatment journey, ensuring you receive the best possible care and support.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026